AU2003278877A1 - Susceptibility gene for human stroke; methods of treatment - Google Patents

Susceptibility gene for human stroke; methods of treatment

Info

Publication number: AU2003278877A1
Authority: AU; Australia
Prior art keywords: treatment; methods; susceptibility gene; human stroke; stroke
Prior art date: 2002-09-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003278877A

Other versions

AU2003278877A8 (en

Inventor

Solveig Gretarsdottir

Jeffrey R. Gulcher

Sigridur Th. Reynisdottir

Gudmar Thorleifsson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Decode Genetics ehf

Original Assignee

Decode Genetics ehf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-25

Filing date

2003-09-25

Publication date

2004-04-19

2002-09-25 Priority claimed from US10/255,120 external-priority patent/US20040091865A1/en

2003-04-18 Priority claimed from US10/419,723 external-priority patent/US20040014099A1/en

2003-09-25 Application filed by Decode Genetics ehf filed Critical Decode Genetics ehf

2003-09-25 Priority claimed from PCT/US2003/029906 external-priority patent/WO2004028341A2/en

2004-04-19 Publication of AU2003278877A8 publication Critical patent/AU2003278877A8/en

2004-04-19 Publication of AU2003278877A1 publication Critical patent/AU2003278877A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Pathology (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003278877A 2002-09-25 2003-09-25 Susceptibility gene for human stroke; methods of treatment Abandoned AU2003278877A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US10/255,120 US20040091865A1 (en)	2001-03-19	2002-09-25	Human stroke gene
US10/255,120		2002-09-25
US10/419,723 US20040014099A1 (en)	2001-03-19	2003-04-18	Susceptibility gene for human stroke; methods of treatment
US10/419,723		2003-04-18
US65012003A	2003-08-27	2003-08-27
US10/650,120		2003-08-27
PCT/US2003/029906 WO2004028341A2 (en)	2001-03-19	2003-09-25	Susceptibility gene for human stroke; methods of treatment

Publications (2)

Publication Number	Publication Date
AU2003278877A8 AU2003278877A8 (en)	2004-04-19
AU2003278877A1 true AU2003278877A1 (en)	2004-04-19

Family

ID=56290488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003278877A Abandoned AU2003278877A1 (en)	2002-09-25	2003-09-25	Susceptibility gene for human stroke; methods of treatment

Country Status (4)

Country	Link
EP (1)	EP1552012A4 (en)
JP (1)	JP2006500068A (en)
AU (1)	AU2003278877A1 (en)
CA (1)	CA2499320A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN109298133B (en) *	2018-07-18	2021-07-13	重庆邮电大学	A method for improving the production yield of detector modules based on edge channel correction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1146888A2 (en) *	1998-10-15	2001-10-24	BioImage A/S	Specific therapeutic interventions obtained by interference with redistribution and/or targetting
ATE387498T1 (en) *	1998-12-30	2008-03-15	Oligos Etc Inc	THERAPEUTIC PDE4D PHOSPHODIESTERASE INHIBITORS
WO2001000851A1 (en) *	1999-06-25	2001-01-04	Memory Pharmaceutical Corporation	Cyclic amp phosphodiesterase isoforms and methods of use
US20030054531A1 (en) *	2001-03-19	2003-03-20	Decode Genetics Ehf,	Human stroke gene

2003
- 2003-09-25 EP EP03770392A patent/EP1552012A4/en not_active Withdrawn
- 2003-09-25 JP JP2004540173A patent/JP2006500068A/en active Pending
- 2003-09-25 AU AU2003278877A patent/AU2003278877A1/en not_active Abandoned
- 2003-09-25 CA CA002499320A patent/CA2499320A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2499320A1 (en)	2004-04-08
JP2006500068A (en)	2006-01-05
EP1552012A2 (en)	2005-07-13
AU2003278877A8 (en)	2004-04-19
EP1552012A4 (en)	2006-06-07

Publication	Publication Date	Title
AU2003301347A1 (en)	2004-05-04	Methods for monitoring treatment of disease
AU2003224788A1 (en)	2003-10-27	Method for treatment of tissue
AU2002332430A1 (en)	2003-02-17	Methods of treating neuropilin-mediated diseases
AU2003293099A1 (en)	2004-06-23	Treatment of dna damage related disorders
GB0302572D0 (en)	2003-03-12	Method of treatment
AU2003259833A1 (en)	2004-03-03	Methods of treating neurodegenerative diseases
AU2003222250A1 (en)	2004-01-23	Treatment of autoimmune diseases
GB0210741D0 (en)	2002-06-19	Methods of therapy
AU2003228295A1 (en)	2003-09-22	Methods of treating hair
AU2003256447A1 (en)	2004-01-23	Treatment of autoimmune skin diseases
AU2003252188A1 (en)	2003-12-12	Method of ore treatment
AU2003270615A1 (en)	2004-04-08	Treatment of steatosis using hyperthermia
AU2003278877A1 (en)	2004-04-19	Susceptibility gene for human stroke; methods of treatment
GB0217493D0 (en)	2002-09-04	Novel methods of treatment
AU2002951913A0 (en)	2002-10-24	Method of treatment
GB0208897D0 (en)	2002-05-29	New method of treatment
GB0221712D0 (en)	2002-10-30	Methods of treatment
GB0327975D0 (en)	2004-01-07	Methods of treatment
AU2003297570A1 (en)	2004-06-18	Treatment of skin diseases
AU2003293581A1 (en)	2004-07-22	Method of identifying therapeutic agents
GB0213198D0 (en)	2002-07-17	Method of treatment
HK1089982A (en)	2006-12-15	Treatment of amyloid-and epileptogenesis-associated diseases
AUPS219902A0 (en)	2002-06-06	Methods of treatment
AU2003904161A0 (en)	2003-08-21	Methods of treatment
GB0207091D0 (en)	2002-05-08	Method of treatment

Legal Events

Date	Code	Title	Description
2005-07-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase